•
Sep 30, 2018

Emergent BioSolutions Q3 2018 Earnings Report

Total Revenue
$174M
Previous year: $149M
+16.2%
EPS
$0.55
Previous year: $0.74
-25.7%
Gross Profit
$100M
Previous year: $105M
-4.3%
Cash and Equivalents
$339M
Previous year: $341M
-0.5%
Free Cash Flow
$148M
Previous year: $20.7M
+613.2%
Total Assets
$1.17B
Previous year: $1.02B
+14.6%

Emergent BioSolutions

Emergent BioSolutions